4
Changes in Ownership
Traws Pharma, Inc. Filed Acc 0002018150-25-000004
Chief Science Officer Virology acquired 18,471 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Pauza Charles David · Chief Science Officer Virology
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-12 | Grant or award : show line 1 in the form | +18,471 | 115,971 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-12 | Grant or award : show line 2 in the form Stock Option (right to purchase) | +73,886 | 73,886 | D |
Loading xslF345X05/form4-12162025_111219.xml…